| IPI00000299 - IRS2, HSPC298 (FRAGMENT). | |
|---|---|
| Uniprot Accession: Q9P084 | |
| Uniprot ID: Q9P084_HUMAN | |
| Mapping: Chr 13, 109204185 - 109236916 | |
| Entrez Gene: 8660 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_12954) |
|---|
| Rat: Irs2, SIMILAR TO INSULIN RECEPTOR SUBSTRATE 2. |
| Mouse: Irs2, INSULIN RECEPTOR SUBSTRATE 2. |
| Human: IRS2, HSPC298 (FRAGMENT). |
| Human: IRS2, INSULIN RECEPTOR SUBSTRATE 2 INSERTION MUTANT (FRAGMENT). |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| cellular_component | C | ND | ||
| insulin receptor binding | F | IEA | IEA | IMP |
| phosphoinositide 3-kinase binding | F | IMP IPI | ||
| signal transducer activity | F | TAS TAS | IEA | ISS |
| receptor activity | F | IEA | IEA | |
| protein domain specific binding | F | IPI | ||
| protein binding | F | IPI | IPI | ISS |
| protein kinase binding | F | IEA | IDA | ISS |
| response to peptide hormone stimulus | P | IDA | ||
| positive regulation of cell proliferation | P | NR | ISS | |
| glucose metabolic process | P | TAS | ISS | |
| signal transduction | P | TAS | IEA | ISS |
| cell proliferation | P | IEA | IMP | ISS |
| insulin receptor signaling pathway | P | IEA | IMP | IMP ISS |
| brain development | P | IEA | IMP | ISS ISS |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| skin/coat/nails phenotype | MP | Un | ||
| cellular phenotype | MP | Un | ||
| adipose tissue phenotype | MP | Un Un Un Un Un | ||
| behavior/neurological phenotype | MP | Un Un Un | ||
| homeostasis/metabolism phenotype | MP | Un Un Un Un Un | ||
| endocrine/exocrine gland phenotype | MP | Un Un Un Un Un Un | ||
| lethality-postnatal | MP | Un | ||
| renal/urinary system phenotype | MP | Un | ||
| nervous system phenotype | MP | Un | ||
| normal phenotype | MP | Un | ||
| cardiovascular system phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un Un Un Un Un | ||
| reproductive system phenotype | MP | Un Un Un | ||
| pigmentation phenotype | MP | Un | ||
| growth/size phenotype | MP | Un Un Un Un Un | ||
| life span-post-weaning/aging | MP | Un |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Diabetes Mellitus, Non-Insulin-Dependent | D | ISS | ||
| Insulin Resistance | D | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| insulin signaling pathway | W | IDAIMP |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Adipocytokine signaling pathway (04920) | Present in KEGG pathway | Present in KEGG pathway | Not present in KEGG pathway |
| Type II diabetes mellitus (04930) | Present in KEGG pathway | Present in KEGG pathway | Not present in KEGG pathway |
| Insulin signaling pathway (04910) | Present in KEGG pathway | Present in KEGG pathway | Not present in KEGG pathway |